Welcome to our dedicated page for The Carlyle Group SEC filings (Ticker: CG), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Carlyle Group Inc. filings document the regulatory record of a publicly traded global investment firm with common stock and listed debt securities. Form 8-K reports cover operating results, earnings presentations, Regulation FD updates, growth objectives, material agreements, direct financial obligations, and capital-structure matters.
Proxy materials describe shareholder voting, board governance, executive compensation, equity awards, and related governance disclosures. Debt-related filings record senior notes, indentures, subsidiary guarantors, and registered securities, while material-event reports document liquidity, capital resources, dividend-policy context, financial condition, and segment-level performance across Global Private Equity, Global Credit, and Carlyle AlpInvest.
WELTERS ANTHONY reported acquisition or exercise transactions in this Form 4 filing.
Carlyle Group Inc. director Anthony Welters reported receiving a grant of 4,450 shares of common stock in the form of restricted stock units. The award was granted at no cash cost per share and increased his directly held position to 47,849 shares after the transaction.
The restricted stock units were granted under The Carlyle Group Inc. Amended & Restated 2012 Equity Incentive Plan and are scheduled to vest on May 1, 2027, if he continues serving on the company’s Board of Directors through that date.
FITT LAWTON W reported acquisition or exercise transactions in this Form 4 filing.
Carlyle Group Inc. director Lawton W. Fitt received a grant of 4,450 shares of Common Stock in the form of a restricted stock unit award under The Carlyle Group Inc. Amended & Restated 2012 Equity Incentive Plan. These units will vest on May 1, 2027, subject to her continued service on the board, and receipt of the shares is deferred to a future date under her deferral election. After this award, she directly holds 78,093 shares of Carlyle common stock.
Rice Derica W reported acquisition or exercise transactions in this Form 4 filing.
Carlyle Group Inc. director Derica W. Rice reported stock-based compensation awards rather than open-market trades. On May 1, 2026, he received two grants of common stock under The Carlyle Group Inc. Amended & Restated 2012 Equity Incentive Plan.
One award covers 2,933 shares at a reference price of $49.44 per share, which vested immediately based on his election to receive vested restricted stock units instead of his annual cash retainer, with delivery of shares deferred to a future date. The second award covers 4,450 restricted stock units that will vest on May 1, 2027, subject to his continued service on the board, with delivery of shares also deferred.
Following these transactions, Rice directly holds 36,657 shares of Carlyle Group common stock, and an additional 4,193 shares are held indirectly by his spouse.
BESCHLOSS AFSANEH MASHAYEKHI reported acquisition or exercise transactions in this Form 4 filing.
Carlyle Group Inc. director Afsaneh Mashayekhi Beschloss received an equity award in the form of restricted stock units. The Form 4 shows a grant of 4,450 RSUs representing Common Stock, awarded at no cash purchase price as part of compensation.
According to the footnote, these RSUs were granted under The Carlyle Group Inc. Amended & Restated 2012 Equity Incentive Plan and will vest on May 1, 2027, if she continues to serve on the Board of Directors through that date. Following this grant, she directly holds 14,689 shares/units linked to Carlyle common stock.
The Carlyle Group Inc. asks shareholders to vote at its virtual 2026 annual meeting on June 3, 2026 on four proposals: electing 13 directors, ratifying Ernst & Young as auditor, approving an amended and restated 2012 Equity Incentive Plan, and a non-binding Say‑on‑Pay vote.
The proxy highlights record 2025 performance, including total shareholder return of 119% from 2023–2025 and U.S. GAAP income before income taxes of $1.2 billion in 2025. Assets under management reached $477 billion as of December 31, 2025. Carlyle also discloses ambitious 2028 targets such as Fee Related Earnings of at least $1.9 billion, management fees of at least $2.8 billion, a FRE margin of 50%+, and Distributable Earnings per share of $6+.
The Board emphasizes refreshed, majority‑independent governance with a diverse 13‑member slate, detailed committee structures, and oversight of strategy, risk (including cybersecurity), culture, and sustainability. The Compensation Committee underlines pay‑for‑performance, heavy use of RSUs and PSUs, robust clawback and stock ownership policies, and a focus on limiting dilution, noting effectively 0% dilution in 2025.
The Vanguard Group filed an Amendment No. 3 to Schedule 13G/A reporting zero shares beneficially owned of Carlyle Group Inc. Common Stock following an internal realignment effective January 12, 2026, under SEC Release No. 34-39538 that disaggregated certain subsidiaries' holdings.
Carlyle Group Inc. director David M. Rubenstein reported two transactions in the company’s common stock. He made a bona fide charitable gift of 100,000 shares of Carlyle common stock, with no sale proceeds received for that transfer.
On the same date, he also completed an open-market sale of 500,000 shares of Carlyle common stock at a price of $46.68 per share. After these transactions, Rubenstein directly owns 27,399,644 shares of Carlyle common stock.
CG submitted a Form 144 reporting the proposed sale of 500,000 shares of Common Stock. The filing lists 500,000 shares as the securities to be sold and records 03/19/2026 as a filing-related date. The shares were originally received in a one-for-one exchange on 01/01/2020.
The Carlyle Group Inc. reports strong 2025 growth with assets under management rising to $477 billion, up 8% from $441 billion. The firm generated $53.7 billion of inflows, a 32% increase, and deployed $54.5 billion while realizing $34.1 billion of proceeds for carry fund investors.
Global Credit was the largest segment with $211.3 billion of AUM, up 10%, while Carlyle AlpInvest reached $102.0 billion, a 20% gain, and Global Private Equity managed about $163.5 billion. Carlyle returned approximately $0.9 billion to shareholders through $505 million of dividends and $400 million of share repurchases.
The carry fund portfolio appreciated 8% in 2025, supported by realizations in private equity, active credit issuance including nine new CLOs, and strong secondary and co‑investment activity. The board reset the share repurchase authorization to $2.0 billion and Carlyle issued $800.0 million of 5.050% senior notes due 2035, adding long-term financing flexibility.